The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases

This publication has 45 references indexed in Scilit:

• The role of cyclooxygenase-2 (COX-2) in two different morphological stages of intestinal polyps in APCΔ474 knockout mice
  Carcinogenesis: Integrative Cancer Research, 2002
• Inhibitory effect of a selective cyclooxygenase‐2 inhibitor on liver metastasis of colon cancer
  International Journal of Cancer, 2002
• COX‐2, prostanoids and colon cancer
  Alimentary Pharmacology & Therapeutics, 2002
• Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
  Nature Reviews Cancer, 2001
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Cyclooxygenase-2 expression in colorectal cancer liver metastases.
  Clinical & Experimental Metastasis, 2000
• Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
  Critical Reviews in Clinical Laboratory Sciences, 2000
• Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
  British Journal of Cancer, 1999
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
  Journal of Clinical Investigation, 1997
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
  Cell, 1996